The gene mutations involved in this genetic disorder primarily involve amyloid precursor protein (AβPP), presenilin 1 and presenilin 2, and mutation carriers progress to AD with 100% certainty (Frost S. M. et al., 2013). The gene discussed is APP; the disease is hereditary disease.